Two cancer drugs could potentially slow or even reverse the effects of Alzheimer’s disease, a new study suggests. Researchers at the University of California San Francisco (UCSF) explored how the ...
Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...
The cancer antibody conjugate market is rapidly expanding, highlighted by increased patent filings and clinical trials. Key opportunities include strategic positioning in antibody, linker, and payload ...
CHENNAI: IIT Madras on Wednesday released a first-of-its-kind cancer genome database covering paediatric leukaemia, colorectal and pancreatic cancers and cancers that together account for a ...
Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit ...
Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s, potentially slowing or even ...
A dual cannabinoid agonist drug candidate is being investigated for its potential in treating wasting syndrome in cancer patients. It demonstrated a weight gain in patients who took the drug versus a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results